BioCardia, Inc.
BCDA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000925741
In the last 90 days, BioCardia, Inc. insiders filed 9 open-market purchases and 0 sales; 21 institutions reported holding it in 13F filings for Q2 2026, worth $1.65M in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in BioCardia, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 23
- −3 vs. Q2 2022
- Shares held
- 1.64M
- −501.2K (−23.5%) vs. Q2 2022
- Total value
- $3.17M
- +$68.0K (+2.2%) vs. Q2 2022
- New holders
- 1
- 7 more added
- Sold out
- 4
- 3 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BCDA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 21 | $1.65M |
| Q1 2026 | 18 | $831.1K |
| Q4 2025 | 20 | $812.3K |
| Q3 2025 | 18 | $551.9K |
| Q2 2025 | 16 | $593.2K |
| Q1 2025 | 12 | $623.8K |
| Q4 2024 | 13 | $272.2K |
| Q3 2024 | 9 | $316.6K |
| Q2 2024 | 10 | $227.8K |
| Q1 2024 | 22 | $790.8K |
| Q4 2023 | 24 | $1.37M |
| Q3 2023 | 16 | $709.6K |
| Q2 2023 | 23 | $4.43M |
| Q1 2023 | 23 | $4.09M |
| Q4 2022 | 25 | $4.87M |
| Q3 2022 | 23 | $3.17M |
| Q2 2022 | 26 | $3.10M |
| Q1 2022 | 24 | $5.49M |
| Q4 2021 | 23 | $5.78M |
| Q3 2021 | 22 | $9.01M |
| Q2 2021 | 20 | $12.3M |
| Q1 2021 | 19 | $13.5M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding BioCardia, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 650,523 | $1.26M | 0.00% | 00.0% | Unchanged |
| CM Management, LLC | 329,000 | $638.0K | 0.71% | 00.0% | Unchanged |
| Family Management Corp | 142,186 | $276.0K | 0.07% | +142,186 | New |
| Susquehanna International Group, LLP | 137,256 | $266.0K | 0.00% | +28,414+26.1% | Added |
| Geode Capital Management, LLC | 92,689 | $179.0K | 0.00% | +1,324+1.4% | Added |
| Advisor Group Holdings, Inc. | 52,843 | $103.0K | 0.00% | +21,000+65.9% | Added |
| Commonwealth Equity Services, LLC | 52,978 | $102.0K | 0.00% | +3,000+6.0% | Added |
| Brown Advisory Inc | 33,085 | $64.0K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 27,407 | $53.0K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 21,545 | $42.0K | 0.00% | −6,767−23.9% | Reduced |
| State Street Corp | 21,000 | $41.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 19,226 | $37.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 14,300 | $28.0K | 0.00% | −500−3.4% | Reduced |
| Bank of New York Mellon Corp | 12,767 | $25.0K | 0.00% | 00.0% | Unchanged |
| LPL Financial LLC | 11,050 | $21.0K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 6,528 | $13.0K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 5,805 | $11.0K | 0.00% | +3,545+156.9% | Added |
| Tower Research Capital LLC (TRC) | 2,398 | $5.00K | 0.00% | +1,640+216.4% | Added |
| UBS Group AG | 1,781 | $3.00K | 0.00% | −3,193−64.2% | Reduced |
| Morgan Stanley | 983 | $2.00K | 0.00% | 00.0% | Unchanged |
| Aspire Private Capital, LLC | 300 | $1.00K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 83 | $0 | 0.00% | +5+6.4% | Added |
| IFP Advisors, Inc | 100 | – | – | 00.0% | Unchanged |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −660,637−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −17,675−100.0% | Sold out |
| Cetera Investment Advisers | 0 | $0 | 0.00% | −12,610−100.0% | Sold out |
| Cutler Group LP | 0 | $0 | 0.00% | −900−100.0% | Sold out |